Brought to you by 
Medtronic acquires Endonetics
04 Apr 2002
Executive Summary
Medtronic has acquired Endonetics, a privately held company that has developed technologies to diagnose and treat gastroesophageal reflux disease (GERD). It paid $67.2mm in cash for the company.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
- Diagnostic Equipment & Supplies
- Monitoring Equipment & Devices
- Surgical Equipment & Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com